Search Results
Apr 14, 2026, 08:00 ET enTrust Immediate Care Now Accepting Traditional Medicaid at Its Houston, TX 77055 Location
Traditional Medicaid is an important step in expanding access to immediate, compassionate healthcare for Houston families," said Dr. Shelise Edwards, MD, FACEP, a board-certified emergency medicine physician and Medical Director of enTrust Immediate Care in Houston, TX."Every person in our community
More news about: enTrust Immediate Care
Apr 14, 2026, 08:00 ET Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies
development, ultimately accelerating our ability to bring these therapies to individuals living with LGMD as quickly as possible," said Nicholas Johnson, MD, CEO of Evolyra Therapeutics.This manufacturing partnership supports Evolyra's development timeline, which includes IND submission in the second
More news about: Andelyn Biosciences
Apr 14, 2026, 08:00 ET Meet the dual shopper: Nearly 1 in 13 for-sale shoppers also engage with rentals
390Baltimore, MD5.6 %
More news about: Zillow
Apr 14, 2026, 06:00 ET The Public Voices Fellowship on Youth Well-being and Power Announces 2026 Fellows
national initiative building the conditions for young people to cultivate purpose in their lives and communities.Caroline Figueroa is an MD–PhD scientist and expert in artificial intelligence, digital health, and youth mental well-being. She is currently a Commonwealth Fund Harkness Fellow
More news about: Hopelab
Apr 14, 2026, 05:00 ET Asolvi launches Protecnus Max, the next generation of cloud-native, agentic AI-powered field service management software for the fire & security industry
accountability matter every day — Protecnus Max was built precisely for that reality. This is what it means to Do More."Antonio Delgado, Protecnus MD and European Lead for the Fire & Security Sector at Asolvi, commented:"It has long been my vision to launch an AI-native, cloud-based
More news about: Asolvi
Apr 14, 2026, 03:49 ET CS Analytical Names Jennifer Roark to Director of Scientific Affairs
13926-2:2017 Pen Systems- Part 2: Plunger stoppers for pen-injectors for medical use. Numerous PDA and Industry Presentations to include MD&M Minneapolis 2018, CPHI Worldwide 2022, PDA Universe of Prefilled Syringes and Injection Devices 2024, and at the PDA Parenteral Packaging Conferences
More news about: CS Analytical
Apr 14, 2026, 03:33 ET TEMSA entrega 15 autobuses eléctricos a Lituania, reforzando así su presencia en Europa
ADANA, Turquía, 14 de abril de 2026 /PRNewswire/ -- TEMSA ha entregado 15 autobuses eléctricos MD9 electriCITY a Lituania, uno de los mercados líderes en Europa en la electrificación del transporte público. Con entregas adicionales
More news about: TEMSA
Apr 14, 2026, 03:30 ET STARCOMPLIANCE UNVEILS NEW WAVE OF INNOVATION AHEAD OF SYNERGY '26
New capabilities advance connected compliance, data visibility, and employee experienceROCKVILLE, Md., April 14, 2026 /PRNewswire/ --
More news about: StarCompliance
Apr 14, 2026, 03:23 ET TEMSA liefert 15 Elektrobusse nach Litauen und baut damit seine europäische Präsenz weiter aus
ADANA, Türkei, 14. April 2026 /PRNewswire/ -- TEMSA hat 15 Elektrobusse des Typs MD9 electriCITY nach Litauen geliefert, einem der führenden europäischen Märkte für die Elektrifizierung des öffentlichen Nahverkehrs. Mit den für das Jahr
More news about: TEMSA
Apr 13, 2026, 16:30 ET Hydro One to Release First Quarter 2026 Results on May 13, 2026 Before Markets Open
the morning of May 13, 2026, before North American financial markets open. A summary of the results will be distributed by newswire and the complete MD&A and financial statements will be posted at
More news about: Hydro One Limited
Apr 13, 2026, 15:00 ET BioOra and Cincinnati Children's Hospital Medical Center Partner to Advance Next-Generation CAR-T Therapy for Children with Leukaemia
anti-tumour activity while improving tolerability compared with earlier-generation CAR-T therapies.As part of the collaboration, Steve Davis, MD, President and Chief Executive Officer of Cincinnati Children's, joins the BioOra Board of Directors.Clinical programme: trial sites and leadershipThe
More news about: BioOra
Apr 13, 2026, 11:22 ET A New Chapter for Gaithersburg, MD: WRS Inc. Breaks Ground on Transformative $1.2 Billion Lakeforest Mall Redevelopment
GAITHERSBURG, Md., April 13, 2026 /PRNewswire/ -- Today, city officials, community leaders, and representatives from WRS Inc. gathered to celebrate the official groundbreaking of the
More news about: WRS Inc.
Apr 13, 2026, 11:00 ET How Sleep Biomarkers Improve Clinical Development and Clinical Assessment in Depression, Upcoming Webinar Hosted by Xtalks
PSG-equivalent sleep staging, and the utility of real world physiology data in supporting both clinical and commercial objectives.Join Andrew Krystal, MD, MS, Professor of Psychiatry and Neurology and Vice Chair for Research, UCSF; David Matthews, PhD, President of Life Sciences,
More news about: Xtalks
Apr 13, 2026, 10:52 ET Florida Cancer Specialists & Research Institute Contributes to Milestone that Expands Treatment Options For Patients With Recurrent Ovarian Cancer
Bradley Monk, MD, FCS medical director of late-phase clinical research, presented the final analysis results at the
More news about: Florida Cancer Specialists & Research Institute
Apr 13, 2026, 10:33 ET Badanie DOORwaY90 firmy Sirtex Medical wskazuje na 100% miejscową kontrolę nowotworu przy pomocy SIR-Spheres®, ustanawiając nowy punkt odniesienia w zakresie terapii Y-90 w przypadku nieoperacyjnego raka wątrobowokomórkowego
pokazują powtarzalność odpowiedzi możliwej do osiągnięcia dzięki spersonalizowanej dozymetrii" – powiedział dr Armeen Mahvash, radiolog interwencyjny w MD Anderson Cancer Center oraz jeden z głównych badaczy w badaniu DOORwaY90. „Wysoki odsetek całkowitych odpowiedzi, ich trwałość oraz zachowanie
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Studie DOORwaY90 společnosti Sirtex Medical prokázala stoprocentní lokální kontrolu nádoru pomocí SIR-Spheres® a stanovila tak nový standard v léčbě HCC pomocí Y-90
konzistentnost odezvy, které lze dosáhnout pomocí personalizované dozimetrie," uvedl Dr. Armeen Mahvash, intervenční radiolog v MD Anderson Cancer Center (Centru pro výzkum rakoviny MD Andersona) a spoluzodpovědný hlavní výzkumník studie DOORwaY90. „Vysoké míry kompletní odezvy, trvalost a zachování jaterních
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Sirtex MedicalのDOORwaY90試験でSIR-Spheres®による100%の局所腫瘍制御が実証され、肝細胞癌に対するY-90療法の新たなベンチマークが確立される
たSIR（Society of Interventional Radiology）年次総会で、口頭発表（ late-breaking oral presentation ）として発表されました。「この12ヵ月間の結果は、個別化線量測定によって達成可能な反応の一貫性を示しています」と、MD Anderson Cancer Centerのインターベンショナル・ラジオロジストであり、DOORwaY90試験の共同治験責任医師であるArmeen Mahvash医師は述べています。「この試験で観察された高い完全奏効率、持続性、肝機能の維持は、医師が放射性塞栓療法を肝臓に直接作用する決定的な治療法として使用する自信を深めるものです。「これらの結果は、医師がY-90療法に期待すべきことの水準を引き上げるものです」とSirtex
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
ventricular recovery, this 90 day data highlights significant patient‑centered benefits of CAVT in intermediate‑high risk PE," said Robert Lookstein, MD, MSc, co‑global principal investigator of the STORM‑PE randomized controlled trial and professor of radiology and surgery at the Icahn School of Medicine
More news about: Penumbra, Inc.
Apr 13, 2026, 09:00 ET Choice Hotels International Brand Sleep Inn Debuts New Design with Openings in Tennessee, Nevada, and Pennsylvania
Scenic Dreams® prototype centers wellness and nature-inspired design. NORTH BETHESDA, Md., April 13, 2026 /PRNewswire/ -- Sleep Inn® by Choice Hotels International, Inc. (NYSE: CHH), one of the world's
More news about: Choice Hotels International, Inc.
Apr 13, 2026, 09:00 ET Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors
operational functions, will be invaluable as we advance zelpultide alfa through late-stage development and prepare for commercialization," said Marc Salzberg, MD, Chairman and Chief Executive Officer of Airway Therapeutics. "Joe brings extensive expertise and relationships in commercializing products in the hospital
More news about: Airway Therapeutics
Apr 13, 2026, 09:00 ET Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors
operational functions, will be invaluable as we advance zelpultide alfa through late-stage development and prepare for commercialization," said Marc Salzberg, MD, Chairman and Chief Executive Officer of Airway Therapeutics. "Joe brings extensive expertise and relationships in commercializing products in the hospital
More news about: Airway Therapeutics
Apr 13, 2026, 09:00 ET Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
12-month results demonstrate the consistency of response achievable with personalized dosimetry," said Dr. Armeen Mahvash, Interventional Radiologist at MD Anderson Cancer Center and Co-Principal Investigator of the DOORwaY90 study. "The high complete response rates, durability and preservation
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
12-month results demonstrate the consistency of response achievable with personalized dosimetry," said Dr. Armeen Mahvash, Interventional Radiologist at MD Anderson Cancer Center and Co-Principal Investigator of the DOORwaY90 study. "The high complete response rates, durability and preservation
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Исследование DOORwaY90 компании Sirtex Medical демонстрирует 100% локальный контроль опухоли с помощью SIR-Spheres®, устанавливая новый ориентир в Y-90 для ГЦК
ответа, достижимого с помощью персонализированной дозиметрии, — сказал д-р Армин Махваш (Armeen Mahvash), интервенционный радиолог в онкологическом центре MD Anderson и один из главных исследователей исследования DOORwaY90. — Высокая частота полного ответа, долговечность и сохранение функции печени, наблюдаемые
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET 서텍스 메디컬의 DOORwaY90 시험, SIR-Spheres®로 100% 국소 종양 제어 입증하며 HCC 치료용 Y-90의 새로운 기준 제시
보여줬다.이번 결과는 캐나다 토론토에서 열린 미국 중재방사선학회 연례학술대회(Society of Interventional Radiology Annual Meeting, SIR Annual Meeting)에서 최신 주요 구두 발표로 소개됐다.MD 앤더슨 암센터(MD Anderson Cancer Center)의 중재방사선의학 전문의이자 DOORwaY90 시험 공동 책임시험자인 아르민 마흐바시(Armeen Mahvash) 박사는 "이 12개월 결과는 개인 맞춤형 선량측정을 통해 달성할 수 있는 반응의 일관성을 보여준다"며
More news about: Sirtex Medical Inc.